BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.02
Delayed Data
As of Feb 23
 +0.22 / +4.58%
Today’s Change
3.95
Today|||52-Week Range
9.25
+2.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-30.1M-45.2M-43.0M-55.1M
 
 
 
 
 
Depreciation304.0K177.0K180.0K483.0K
 
 
 
 
 
Total Other Cash Flow-534.0K5.2M10.7M8.8M
 
 
 
 
 
Funds From Operations-30.3M-39.9M-32.1M-45.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.8M-1.3M-19.0M7.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-26.5M-38.6M-13.1M-53.4M
 
 
 
 
 
 
InvestingIncrease In Investments-24.0M-73.9M-53.8M-14.1M
 
 
 
 
 
Decrease In Investments20.3M34.0M42.4M42.7M
 
 
 
 
 
Capital Expenditures-30.0K-106.0K-5.1M-5.3M
 
 
 
 
 
Fixed Asset Disposal50.0K0.000.004.0K
 
 
 
Other Investing - Sources157.0K1.0K0.000.00
 
 
 
Net Cash Flow Investing-3.5M-40.0M-16.5M23.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00-1.5M--
 
 
Long Term Borrowings0.000.000.0023.0M
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale25.1M111.9M5.5M317.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing5.2M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing30.3M111.9M4.0M23.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash273.0K33.4M-25.6M-6.9M